SAB Biotherapeutics, Inc 10-K for FY2024
SAB Biotherapeutics, Inc. (SABS)
10-K
2025-03-31
For: 2024-12-31
View Original
Added on
April 10, 2026
About this 10-K
SAB Biotherapeutics, Inc filed this 10-K on March 31, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.32M
- down 40.9% from $2.24M a year earlier
- Net loss
- $34.11M
- compared with a net loss of $42.19M a year earlier
- Diluted EPS
- -$3.68
- compared with -$7.64 a year earlier